1. Diabetes epidemic play plus LLY is diversified.
2. Weekly chart breakout
No need to pump or debate with naysayers I have put my money where my mouth is and will cash in on LLY.
Happy trading everyone.
Also must state a casino gamble is with HESG
They are just getting into Medical Marijuana and are merging with Medical Marijuana, Inc in a few months
This will make ONLY 2 PLAYERS in the Medical Marijuana industry
1. Cannabis Science (CBIS)
2. HESG & MJNA
Where is this diversity, they have sold two device companies all ready, they will lose patent on Zyprexa and they dont have a replacment, they are selling assetts, and insulin will go generic one day. By the way i am ex lilly and loving it
Today LLY has market value of $41 Bil which is 27 Bil Euros. At the low earlier this year the Market Cap was $29 Bil which was 22 Bil Euros. So for a European Corporate buyer the price recovery is much less. Aso a buyer will consider the following:
1. LLY gets nearly 50% of its earnings from non-dollar sales.
2. Borrowing costs for a large corporaion are at bargain levels.
3. Most of the Share prices of international pharma companies have moved up more than LLY
Looks like it's well worth holding onto, and adding to on any weakness.